Last updated: 2026-10-14 20:36:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
West Pharmaceutical Services, Inc. (WST) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $374.95, with a market capitalization of $25.87B and a P/E ratio of 46.32. Over the past 52 weeks, its price has ranged from $223.83 to $386.00. This page covers its latest market performance, valuation, price trends and company information.
$25.87B | |
$372.21 | |
$475.35 | |
$7.68 | |
$371.82 | |
358.60K | |
620.87K | |
46.32 | |
$386.00 | |
$223.83 | |
0.22% | |
-- |
West Pharmaceutical Services, Inc. (WST) is trading at $363.90 in after-hours trading as of 2026-10-14 20:10:00, down 2.13% ($7.92) from the regular-session close of $371.82.
After-hours trading shows how investors are pricing WST after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, West Pharmaceutical Services, Inc. (WST) moved from $376.76 to $374.95, representing a decline of 0.48% ($1.81).
The stock traded between $359.49 and $381.16 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 475.58 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 93.2%
WST is currently trading at $374.95, placing it 93.2% of the way from its 52-week low of $223.83 to its 52-week high of $386.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 10800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of West Pharmaceutical Services, Inc. (WST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.